The free dividend tracker to help you grow your wealth. Link your brokerage accounts and MerryDiv automatically syncs your holdings and dividends.
Data last updated: Oct 19, 2026
Snapshot (as of Oct 19, 2026): Elevance Health, Inc. (ELV) pays a $6.86 annual dividend ($1.72 quarterly), yielding 1.61% at $428.26/share. Next ex-dividend date 2026-09-10. 13+ consecutive years of dividend growth. Source: Yahoo Finance, aggregated by MerryDiv.
Dividend Yield: 1.61%
Annual Dividend: $6.86 per share
Payout Ratio: 30.4%
Ex-Dividend Date: 2026-09-10
Dividend Frequency: quarterly
Sector: Healthcare
Years of Dividend History: 16
Elevance Health, Inc. dividend reflects a company that covers the full spectrum of health benefits, from individual and employer plans under the Anthem Blue Cross and Blue Shield brand to pharmacy services through CarelonRx and behavioral health through Carelon. ELV pays a quarterly dividend, with a trailing annual rate of $6.86 per share and a next ex-dividend date of September 10, 2026. The current yield stands at 1.67%. With a beta of 0.711, ELV stock moves less than the broader market, which suits investors who prioritize dividend growth over immediate income.
Elevance Health, Inc. pays out 30.4% of earnings as dividends, a payout ratio classified as conservative (below 40%). That low payout leaves substantial room to sustain and grow the dividend even if earnings face pressure, and ELV's diversified revenue base, spanning risk-based health plans, fee-based administrative services, pharmacy benefits, and specialty care, supports demand across multiple lines. Elevance Health, Inc. dividend safety faces its most credible test from regulatory and reimbursement risk inherent in Medicare and Medicaid plan operations, which represent a meaningful portion of the business.
Elevance Health, Inc. dividend history shows a CAGR of 14.7% per year from 2011 to 2025. The per-share dividend grew from $1.00 to $6.84 over that period (2026 data is partial and excluded from the CAGR calculation). The smallest annual increase in the window was 3.8% in 2017, which shows that even in slower years, ELV did not freeze the dividend.
| Period | CAGR | From | To |
|---|---|---|---|
| 3-Year | +10.1% | $5.12 (2022) | $6.84 (2025) |
| 5-Year | +12.5% | $3.80 (2020) | $6.84 (2025) |
| 10-Year | +10.6% | $2.50 (2015) | $6.84 (2025) |
ELV fits growth-and-income investors who want a rising dividend from a large health benefits business and are willing to accept a low current yield in exchange for above-average growth. The yield of 1.67% is classified as low (below 2%), and it sits above the 5-year average yield of 1.3%, meaning the current entry point offers slightly more income than the historical norm. The 30.4% payout ratio gives the company room to keep raising the dividend without straining earnings. Thirteen consecutive years of increases and a 14.7% CAGR are the core appeal. The trade-off is straightforward: income today is modest, and the investment case rests on continued dividend growth rather than yield.
| Payment Date | Amount per Share |
|---|---|
| 2026-09-10 | $1.7200 |
| 2026-06-10 | $1.7200 |
| 2026-03-10 | $1.7200 |
| 2025-12-05 | $1.7100 |
| 2025-09-10 | $1.7100 |
| 2025-06-10 | $1.7100 |
| 2025-03-10 | $1.7100 |
| 2024-12-05 | $1.6300 |
| 2024-09-10 | $1.6300 |
| 2024-06-10 | $1.6300 |
| Year | Total Dividends |
|---|---|
| 2026 | $5.1600 |
| 2025 | $6.8400 |
| 2024 | $6.5200 |
| 2023 | $5.9200 |
| 2022 | $5.1200 |
Project income from ELV with the ELV dividend calculator or track your full portfolio with the dividend tracker.